Lars C. Wallentin
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Acute Myocardial Infarction Research 272
- Atrial Fibrillation Management and Outcomes 252
- Antiplatelet Therapy and Cardiovascular Diseases 222
- Surgery 111
- Coronary Interventions and Diagnostics 53
- Lipoproteins and Cardiovascular Health 46
- Co-authors
- Stefan Karl James (168 shared papers)Salim Yusuf (99 shared papers)Agneta G Siegbahn (178 shared papers)Stuart J. Connolly (108 shared papers)Bertil Lindahl (85 shared papers)Michael D. Ezekowitz (85 shared papers)Paul A. Reilly (59 shared papers)Jonas Oldgren (102 shared papers)
- Journals
- European Heart Journal (134 papers)Journal of the American College of Cardiology (113 papers)American Heart Journal (79 papers)Circulation (77 papers)Heart (30 papers)
- Partner nations
- SwedenUnited StatesCanada
In The Last Decade
Lars C. Wallentin
897 papers receiving 103.2k citations
Lars C. Wallentin's Hit Papers
Peers
Comparison fields: 5 of 188
- Cardiology and Cardiovascular Medicine 74.5k
- Internal Medicine 4.1k
- Hematology 4.5k
- Surgery 13.4k
- Nephrology 1.8k
Countries citing papers authored by Lars C. Wallentin
This map shows the geographic impact of Lars C. Wallentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars C. Wallentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars C. Wallentin more than expected).
Fields of papers citing papers by Lars C. Wallentin
This network shows the impact of papers produced by Lars C. Wallentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars C. Wallentin. The network helps show where Lars C. Wallentin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars C. Wallentin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 920 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dabigatran versus Warfarin in Patients with Atrial Fibrillation Hit paper breakdown → | 2009 | 8958 |
| 2 | Apixaban versus Warfarin in Patients with Atrial Fibrillation Hit paper breakdown → | 2011 | 7076 |
| 3 | Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Hit paper breakdown → | 2009 | 5554 |
| 4 | ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Hit paper breakdown → | 2012 | 5467 |
| 5 | COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS Hit paper breakdown → | 1994 | 2860 |
| 6 | Third universal definition of myocardial infarction Hit paper breakdown → | 2012 | 2471 |
| 7 | Discovery and refinement of loci associated with lipid levels Hit paper breakdown → | 2013 | 2415 |
| 8 | Third Universal Definition of Myocardial Infarction Hit paper breakdown → | 2012 | 2322 |
| 9 | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Hit paper breakdown → | 2007 | 2265 |
| 10 | Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Hit paper breakdown → | 2007 | 1481 |
| 11 | Large-scale association analysis identifies new risk loci for coronary artery disease Hit paper breakdown → | 2012 | 1351 |
| 12 | Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease Hit paper breakdown → | 2000 | 1023 |
| 13 | Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden Hit paper breakdown → | 2007 | 958 |
| 14 | Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation Hit paper breakdown → | 2011 | 917 |
| 15 | Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials Hit paper breakdown → | 2017 | 897 |
| 16 | Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Hit paper breakdown → | 2010 | 810 |
| 17 | Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome Hit paper breakdown → | 2011 | 791 |
| 18 | Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials Hit paper breakdown → | 2002 | 753 |
| 19 | Common variants associated with plasma triglycerides and risk for coronary artery disease Hit paper breakdown → | 2013 | 732 |
| 20 | The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients Hit paper breakdown → | 2013 | 723 |
About Lars C. Wallentin
Lars C. Wallentin is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Hematology, Rheumatology and Genetics, having authored 920 papers that have together received 109.7k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (272 papers), Atrial Fibrillation Management and Outcomes (252 papers), Antiplatelet Therapy and Cardiovascular Diseases (222 papers), Coronary Interventions and Diagnostics (53 papers), Lipoproteins and Cardiovascular Health (46 papers), Blood Coagulation and Thrombosis Mechanisms (38 papers), Genetic Associations and Epidemiology (29 papers) and Inflammatory Biomarkers in Disease Prognosis (23 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (74.5k citations), Internal Medicine (4.1k citations), Hematology (4.5k citations), Surgery (13.4k citations) and Nephrology (1.8k citations). Lars C. Wallentin has collaborated with scholars based in Sweden, United States and Canada. Frequent co-authors include Stefan Karl James, Salim Yusuf, Agneta G Siegbahn, Stuart J. Connolly, Bertil Lindahl, Michael D. Ezekowitz, Paul A. Reilly, Jonas Oldgren, Steen Husted and John W. Eikelboom. Their work appears in journals such as European Heart Journal, Journal of the American College of Cardiology, American Heart Journal, Circulation and Heart.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.